Both in Pharmaceuticals
Nature's Sunshine Products vs CAMP4 Therapeutics
Over the past year NATR returned −6.8% and CAMP returned −1.7%; their daily moves had a correlation of 0.01.
NATR −6.8% CAMP −1.7%Growth of $1, one year, split-adjusted
| Metric | NATR | CAMP |
|---|---|---|
| Price | $12.25 | $3.96 |
| Market cap | $215.5M | $248.5M |
| Today | −0.24% | +1.54% |
| 1 month | −2.7% | +3.1% |
| 6 months | −54.1% | −2.2% |
| Year to date | −43.2% | −35.4% |
| 1 year | −8.7% | +2.6% |
| Revenue growth (YoY) | +1.9% | +18.8% |
| Gross margin | 73.7% | 100.0% |
| Net margin | 3.0% | −1884.8% |
| P/E (TTM) | 11.9× | — |
| Price / sales | 0.4× | 58.9× |
| Net cash | $82.5M | $86.4M |
| Dividend yield | — | — |
| Volatility (60d) | 48.0% | 84.1% |
| Short % of float | 6.4% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).